developments in the mastocytosis field at ash 2020
Published 3 years ago • 357 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
2:56
insights into the treatment and management of advanced systemic mastocytosis
-
4:54
aml treatment: ash 2020 and beyond
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
56:14
february 17, 2023 | post ash cme series 2022: classical hematology
-
10:01
ask the experts: answers to common questions about sm
-
47:26
post ash22 mds summary
-
9:14
upcoming updates in the mpn field at ash 2020
-
4:46
management strategies for advanced systemic mastocytosis
-
3:10
is there a benefit to rituximab maintenance after first-line bendamustine-rituximab for mcl?
-
2:55
current and emerging treatments for mf: an update from ash 2023
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
1:44
emerging novel agents for the treatment of mastocytosis
-
5:21
systemic mastocytosis: current treatments and emerging targeted agents
-
2:41
an overview of the latest advances in hematology
-
1:58
mastocytosis: impact of covid-19 on clinical practice
-
1:46
updated analyses from the pathfinder trial: avapritinib therapy in advanced systemic mastocytosis
-
1:55
updates at ash 2020 on bispecific antibodies in mm
-
2:13
splicing mutations in post-et/post-pv myelofibrosis
-
2:37
current approaches to treating systemic mastocytosis
-
1:46
unmet needs and challenges in advanced systemic mastocytosis